A 63-year old male, after cadaveric kidney transplantation 23 years ago was admitted to the hospital due to sudden and severe deterioration of kidney function (from creatinine 2.45 mg/dL to 7.06 mg/dL with corresponding estimated glomerular filtration rate-GFR 8 ml/min) with uremic symptoms, hyperkalemia, volume overload and refractory hypertension (180/90 mmHg). He had a history of transplant renal artery stenosis (TRAS) and double-angioplasty and stenting procedure 2 and 22 years after transplantation. Cyclosporine was discontinued, and therapy of hypertension was modified, however only slight improvement in laboratory parameters and blood pressure (BP) control was achieved. Re-initiation of dialysis therapy was considered assuming end-stage renal failure occurrence.
The ultrasound showed normal size and structure of the transplanted kidney with a length of 110 mm, parenchymal layer of 13-17 mm and normal echogenicity, without impairment of urine outflow (Fig 1 A,B) . Doppler ultrasound revealed haemodynamically significant stenosis localized in the mid-proximal part of graft artery, most likely in the stent, with an increase in systolic peak velocity (SPV) up to 416 cm/s ( Fig 1C) and reduced resistive indexes (RI) at parenchymal level to 0.53 and extended acceleration time to 0.09 s (Fig 1D) .
Despite advanced graft failure but with the normal echogenicity on ultrasound, a decision on angioplasty was made.
Arteriography confirmed the presence of in-stent restenosis (ISR) implanted into the proximal segment of the renal artery (Fig 1E) . The angioplasty of restenosis using a 5 mm diameter balloon and an IN PACT PACIFIC (drug coated) 5 x 40 mm balloon was performed with no residual stenosis after revascularization. (Fig 1F,G) . In few days after angioplasty the recovery of graft function was achieved to stable values observed in recent years (serum creatinine 2.0 mg/dl), and blood pressure lowering allowing for reduction of antihypertensive drugs doses (130/80 mmHg).
TRAS represents approximately 75% of vascular complications after kidney transplantation, with the incidence ranges from 6% to 23%, depending on the diagnostic criteria and studied population. TRAS mainly occurs from 3 months to 2 years after transplantation, but it can present at any time leading to deterioration of function or even graft loss [1] .
Doppler ultrasonography is used as initial imaging modality, and SPV > 2.5 m/s is the best discriminating index for TRAS [2, 3] . Interventional treatment of choice is percutaneous transluminal angioplasty (PTA) with or without stenting [2, 3] . Restenosis that develops within the first 6 to 9 months after primary intervention is the main complication of PTA, with the incidence ranging from 15% to 28% and increasing risk with second stenting [3] .
The mechanism of ISR in the transplanted renal arteries is intimal hyperplasia, thus use of paclitaxel-coated balloon inhibiting arterial smooth muscle proliferation, migration, and extracellular matrix formation may be favourable in treating restenosis potentially decreasing the incidence of late thrombosis without antiplatelet therapy [4] .
The presented case shows that even many years after transplantation, it is worth looking for the reasons for severe and sudden deterioration of allograft function, attempt treatment and give a chance to celebrate the next anniversaries of life with a transplanted kidney. 
